Blood lead testing, screening, screening-related services, and diagnostic evaluations as required by § 2602 of this title are reimbursable under health insurance contracts and group and blanket health insurance under §§ 3337 and 3554 of Title 18, respectively.
Structure Delaware Code
Chapter 26. CHILDHOOD LEAD POISONING PREVENTION ACT
§ 2601. Short title; definitions.
§ 2602. Physicians and health-care facilities to screen children.
§ 2603. Screening prior to child care or school enrollment.
§ 2604. Reimbursement by third-party payers.